U
AGN

UBS’s Allergan plc AGN Stock Holding History

UBS’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$13.2M Buy
54,500
+16,900
+45% +$3.78M 0.01% 1235
2014
Q2 		$8.39M Sell
37,600
-8,004
-18% -$1.66M 0.01% 1511
2014
Q1 		$9.39M Buy
45,604
+44,074
+2,881% +$8.73M 0.01% 1312
2013
Q4 		$257K Sell
1,530
-36,670
-96% -$5.73M ﹤0.01% 5018
2013
Q3 		$5.5M Buy
38,200
+37,800
+9,450% +$5.04M 0.01% 1628
2013
Q2 		$51K Buy
+400
New +$45.3K ﹤0.01% 6714

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS's AGN Position: Q3 2014 in Review

UBS increased its Allergan plc (AGN) stake by 8.9% in Q3 2014, buying an estimated $18.2M and bringing the position to 998,423 shares worth $241M. The position accounts for 0.18% of the portfolio, ranked #124.

UBS first reported a position in AGN in Q2 2013 and has held it in 6 quarters since. 753 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • UBS held 998,423 shares of Allergan plc worth $241M as of Q3 2014.
  • UBS bought 81,242 Allergan plc shares in Q3 2014, an estimated $18.2M.
  • Allergan plc made up 0.18% of UBS's portfolio in Q3 2014, its #124 holding.
  • UBS first reported a position in Allergan plc in Q2 2013 and has held it in 6 quarters since.
  • 753 funds tracked by Wall St. Rank held Allergan plc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.